Physician

Michael Schmerler, MD

According to 2025 Medicare claims, Michael Schmerler, MD (NPI: 1649380619) practices neurology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Hamilton, OH. This provider's primary affiliated billing organization is RIVERHILLS HEALTHCARE INC (NPI: 1205943651; TIN: 311412447) and primary practice location at 45212-2280. Schmerler is affiliated with the Healthcare Solutions Network (ACO ID: A3283), participating under the MSSP model.

Schmerler's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 634 traditional Medicare patients, billed 22,689 HCPCS/CPT codes, and received $826,167 in Medicare payments. The top billing code was 95816 (Measurement of brain wave activity (eeg), awake and drowsy). Part D data shows 3,499 prescription claims across 612 beneficiaries totaling $730,518 in drug costs, led by Ingrezza (Valbenazine Tosylate). 2017 DME data shows 12 claims. Open Payments data shows 2 records totaling $246. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $166,922 and ending at $826,167. Concurrently, Part D prescription costs have fallen sharply in recent years, from $2,414,888 to $730,518. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,040	2,307	$166,922
2016	1,167	31,181	$732,831
2017	1,311	26,418	$836,488
2018	1,079	35,103	$1,030,903
2019	926	14,526	$518,842
2020	681	13,468	$599,693
2021	761	18,864	$708,662
2022	614	10,777	$389,698
2023	638	20,917	$760,206
2024	634	22,689	$826,167

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	724	4,128	$2,414,888
2016	735	4,454	$3,027,884
2017	706	4,212	$3,648,193
2018	707	4,349	$3,644,131
2019	703	4,305	$3,677,731
2020	612	3,788	$2,714,818
2021	559	3,491	$2,098,439
2022	568	3,149	$1,629,720
2023	581	3,150	$1,212,033
2024	612	3,499	$730,518

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	13	$510
2017	N/R	12	$401
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95816	Measurement of brain wave activity (eeg), awake and drowsy	49	49	$284
95819	Measurement of brain wave activity (eeg), awake and asleep	97	100	$163
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	233	233	$113
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	333	415	$88
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	42	87	$43

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ingrezza	Valbenazine Tosylate	27	810	$230,643
Avonex Pen (4 Pack)	Interferon Beta-1a	17	476	$129,334
Copaxone	Glatiramer Acetate	16	448	$88,707
Emgality Pen	Galcanezumab-Gnlm	26	960	$22,248
Tiagabine Hcl	Tiagabine Hcl	28	736	$16,901

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$246	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael Schmerler, MD?

Tedicare shows public-source Medicare data for Michael Schmerler, MD (NPI 1649380619), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Schmerler, MD have ACO affiliation data?

Michael Schmerler, MD is shown with ACO affiliation data for Healthcare Solutions Network (MSSP, ACO ID A3283).

What billing organization is linked to Michael Schmerler, MD?

Michael Schmerler, MD is linked to RIVERHILLS HEALTHCARE INC (billing NPI 1205943651) in the available physician profile data.

Does Michael Schmerler, MD have Open Payments data?

Michael Schmerler, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.